Asthma Screening Study
Future Participant Registry
Asthma Screening Study
Future Participant Registry
Embedded Files
Future Participant Registry
Investigator Initiated | Lugogo
Proactively evaluate potential subjects with asthma who have expressed interest in participating in clinical asthma research trials at Michigan Medicine.
Studies Currently Enrolling
Therapeutic Trials
Studies Currently Enrolling
Therapeutic Trials
AIM4: Next Step
AIM4: Next Step
IRB No. HUM00258497
Regeneron | R668-AS-2373 | Qiu
Study designed to evaluate the efficacy of Dupilumab (Dupixent) added to Medium Dose ICS/LABA in comparison to ICS Dose escalation to High Dose ICS/LABA in Patients with Uncontrolled Asthma
AIRLYMPUS
AIRLYMPUS
IRB No. HUM00262749
Sanofi | ACT18301 | Qiu
IRB No. HUM00262749
Sanofi | ACT18301 | Qiu
A randomized, Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to investigate the efficacy, safety, and tolerability of subcutaneous lunsekimig (SAR443765) in adult participants with high-risk asthma who are not currently eligible for biologic treatment.
IRB No. HUM00206820
Sanofi | LPS16676 | Lugogo
Study assessing the long-term effect of Dupilumab (Dupixent) on prevention of lung function decline in patients with uncontrolled moderate to severe asthma.
BRISOTE
IRB No. HUM00263449
AstraZeneca | D3250C00101 | Mohan
A Multicentre, Randomized, Double-Blind, Parallel Group, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting β2-Agonist
C4531029
C4531029
IRB No. HUM00270205
Pfizer | C4531029 | HUM00270205 | Lugogo
IRB No. HUM00270205
Pfizer | C4531029 | HUM00270205 | Lugogo
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate The Efficacy and Safety of PF-07275315 in Adult Participants within Adequately Controlled Moderate-to-Severe Asthma
NEW Studies Enrolling Soon!
NEW Studies Enrolling Soon!
Joining one of our study trials may be right for one of your patients.
Joining one of our study trials may be right for one of your patients.
POLARIS
IRB No. HUM00279625
Winward Bio AG |WB-2101 | HUM00279625 | Lugogo
A Phase 2 Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants with Moderate or Severe Asthma
Thank you for your consideration and referrals.
Thank you for your consideration and referrals.
Report abuse